体育平台

||

To defeat diabetes is our social responsibility

体育平台Our social responsibility strategy introduces new long-term ambitions to accelerate prevention to halt the rise of diabetes, provide access to affordable care for vulnerable patients in every country and to continue to drive innovation to improve lives.

 



The first steps in our strategy to defeat diabetes
 


Taking action in cities

Reaching
100,000 children 
with type 1 diabetes

We expand our 
Changing Diabetes® in Children programme 

Obesity

Reducing
the price of
human insulin

We reduce the ceiling price of human insulin from 4 to 3 USD

Social and cultural dynamics

Donating 
DKK 15 million to relief efforts

We extend our partnership with Red Cross partners



What will each step mean for people living with diabetes?
 


No child should die from type 1 diabetes

We are expanding our Changing Diabetes® in Children programme to reach 100,000 children by 2030. Since the programme’s first child was enrolled in 2009, we have helped more than 25,000 children with type 1 diabetes get access to medical care and life-saving medicine in low-resource settings. 

Our Changing Diabetes® in Children programme

 


Reduced price of human insulin in low- and middle-income countries

As part of our existing Access to Insulin Commitment, we are reducing the ceiling price of human insulin from USD 4 to USD 3 per vial in 76 low- and middle-income countries. This applies to Least Developed Countries as defined by the United Nations other low-income countries as defined by the World Bank  and middle-income countries where large low-income populations lack sufficient health coverage. We will also address challenges in insulin distribution and healthcare capacity that often prevent low-cost insulin from reaching the most vulnerable people.

Our access to insulin commitment

 


Improved care for vulnerable populations displaced by conflict

We are extending our partnership with the International Committee of the Red Cross and the Danish Red Cross until 2023 and supporting with a donation of DKK 15 million. Our Partnering for Change programme, launched in 2018, will continue to provide help to the most vulnerable patient groups during humanitarian crisis, including the integration of diabetes and hypertension care into the Red Cross’s global health operations.

Our work with Red Cross partners

 



What more are we doing to defeat diabetes?
 



Expanding patient support options in the U.S.
 

People with diabetes using Novo Nordisk insulin who have lost health insurance coverage because of a change in job status due to COVID-19 may be eligible for a free 90-day supply of insulin through Novo Nordisk’s Diabetes Patient Assistance Program.

See how we are supporting US patients

 



Helping to prevent type 2 diabetes in cities
 

We are collaborating with leaders from over 25 cities to tackle the rise of type 2 diabetes in urban environments. 

With nearly two-thirds of all people with diabetes living in urban areas, cities are an important focal point for tackling the problem.

Learn about our efforts to prevent type 2 diabetes in cities

 



Supporting humanitarian relief efforts during the COVID-19 pandemic
 

We are donating and shipping free insulins to organisations providing humanitarian relief, such as UNICEF, UNRWA and our Red Cross partners, for six months. The total value of the donation is more than DKK 20 million.

Learn more about our efforts in humanitarian crisis

 



Working in partnership
with UNICEF
 

Globally, 40 million children under the age of 5 are overweight putting many young people at risk of early onset of type 2 diabetes.

Together with UNICEF, we are working to help prevent childhood overweight and obesity and help support actions that make a difference.

See how we are working to prevent childhood obesity

 


How else are we fighting diabetes?
 


Prevention or cure? In type 1 diabetes, we are working on both

体育平台As the number of people diagnosed with type 1 diabetes continues to rise, we are working to better understand what causes the disease - and how to prevent or cure it.

Our aim is to find new therapies that can delay, prevent and even cure type 1 diabetes.

Here’s how far we’ve come

 


Scaling up China’s fight against type 2 diabetes

Could digital health tools provide the solution to China’s burgeoning diabetes crisis? Our CEO Lars Fruergaard Jørgensen believes so.

Find out why

 


Are you at risk?

Your risk of developing type 2 diabetes is based on many factors - being middle aged or older, being overweight, or having a family history of diabetes.  Progression is gradual, so you may not even notice the symptoms until they become obvious.

Take the type 2 diabetes risk test and help defeat diabetes